Managing abnormal liver tests in children with inflammatory bowel disease

4Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose of reviewLiver test abnormalities in children with inflammatory bowel disease (IBD) are usually insidious in onset. By the time that symptoms referable to liver disease have appeared, the liver injury may be well advanced. It is, therefore, important that children with an incidental finding of abnormal liver tests are investigated in an appropriate and timely manner.Recent findingsThe most prevalent cause of liver test elevations in paediatric IBD is immune-related liver disease, including primary sclerosing cholangitis, autoimmune sclerosing cholangitis, and autoimmune hepatitis. Although less common, drugs used in the treatment of IBD can also cause liver injury. The diagnosis of drug-induced liver injury relies largely on excluding other causes of liver injury, such as viral hepatitis, nonalcoholic fatty liver disease, and biliary and vascular complications.SummaryThis review highlights an avenue to a step-wise approach for investigating children with IBD and silent liver test elevations. Central to the timing of diagnostic actions is grading the severity of liver test elevations.

Cite

CITATION STYLE

APA

Van Rheenen, P. F. (2021, October 1). Managing abnormal liver tests in children with inflammatory bowel disease. Current Opinion in Pediatrics. Lippincott Williams and Wilkins. https://doi.org/10.1097/MOP.0000000000001045

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free